Corporate Innovation FAQ
Corporate Innovation FAQ
Straight answers for corporate innovation and R&D teams — stage-gate fit, build/buy/partner framing, confidentiality, and how to evaluate Commercify on real projects.
Where does Commercify fit in our stage-gate process?
At the gates. A generated strategy is structured evidence for a go/no-go decision: market size and growth, competitive position, recommended commercialization pathway, pricing potential, and explicit risks. Teams use it to give early-gate reviews the same analytical rigor that later gates get, without commissioning a consulting study for every candidate project.
Does it handle build vs. buy vs. partner decisions?
The strategy's pathway recommendation covers the commercialization side of that framing — whether a technology is best taken to market directly, licensed out, or advanced through a strategic partnership — with a rationale and the conditions under which the alternative wins. It won't model your internal build costs, but it supplies the market half of the decision.
How is this different from innovation management software like Brightidea or ITONICS?
Innovation management platforms govern the pipeline: idea intake, scoring, stage-gates, portfolio dashboards. Commercify generates the commercialization analysis for a specific technology inside that pipeline. One manages which projects exist; the other tells you how a given project reaches the market. They're complementary, not substitutes.
Can we run our whole innovation portfolio through it?
The free generator handles one technology at a time, which works for evaluating it on a few real projects. Portfolio-scale analysis — screening dozens of R&D projects, comparing across the pipeline — is what Commercify for Programs is being built for with design partners, and corporate innovation teams with a live portfolio are exactly who we want to build it with.
What about confidentiality for internal R&D projects?
Describe projects at the level you'd use in an external partner conversation: application, stage, and market context, without proprietary technical detail. The description you submit is processed by our AI provider to generate the report. That level of description is enough for a useful strategy — the analysis runs on market context, not trade secrets. For engagements under NDA, the design partner program is the right channel.
Can it help us scout university technologies and research partners?
Yes. The university directory profiles 150+ tech transfer offices searchable by technology focus, and the licensing guide covers how corporate teams engage TTOs — from sponsored research to exclusive licenses.
University tech transfer directory →·How to license university technology →
What does the analysis actually cover for an internal technology?
The same structure as any strategy: market assessment with sizing, competitive landscape, recommended pathway with rationale, three target segments, pricing strategy, phased launch plan, risks with mitigations, five validation experiments with pass/fail metrics, and relevant external funding or partnership programs. For internal projects, the validation experiments are often the most immediately actionable section — cheap tests to run before the next gate review.
How do we evaluate Commercify without a procurement cycle?
Pick one or two real R&D projects, run them through the free generator, and put the output next to your last gate-review packet. It costs nothing, needs no contract, and the comparison tells you more than a demo would.
Still have questions?
The fastest way to understand Commercify is to generate a strategy for your own technology — it's free.